Published Study Supports Global Medical’s Expandable Lateral Technology

On May 15, Global Medical, Inc. (GMED) reported the results of a medical study that supported the benefits of the company’s Globus expandable lateral spacers. The study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up” was published in the Journal of Spine Surgery. Dr. Joseph O’Brien, MD, orthopedic surgeon at Washington Spine and Scoliosis Institute and Dr. Richard Frisch, orthopedic surgeon at Southeastern Spine Institute, co-authored the study.


Rocket Tickers detected the news and issued an alert at 4:15 pm. The next trade took place for $49.70 at 4:28 pm. The stock opened for regular market trading the next morning at $49.81. Global Medical’s stock price moved higher on the news and continued to rise over the next five trading days. The stock closed at $52.84 on May 23 for a gain of over 6%.

Visit the Knowledge Center for more information about clinical trials and how to trade them.

Check out our latest Live Webinar which provides more information about price patterns after clinical trial announcements and how to trade them.

Subscribe here if you would like to start receiving these signals in real-time and start trading!